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Summary
background/aim
Adherence is the extent to which a patient´s behav-
iour towards medication corresponds with the agreed 
recommendations from a health care provider. Non-
adherence to long-term therapy for chronic diseases 
in developed countries is on average 50%. Poor adher-
ence is the primary reason for poor outcomes, and is 
potentially a waste of health care resources.
The objective of the Zagreb study was to assess the 
extent of adherence among the outpatients with long-
term medication.
Methods
Patients with chronic diseases were interviewed during 
their visit to a public pharmacy. Their anonymity was 
guaranteed. The questionnaire was standardized and 
approved by the Ethical Committee. 635 questionnaires 
were collected in total (2000 were distributed). The study 
design was cross-sectional. The evaluation of pharma-
cist-patient relationships was also included in the study. 
84 pharmacists volunteered to participate in the study.
Results
The average adherence to long-term medication was 
41.7%. It was even lower in case of hypertensive pa-
tients (39%). The most frequent reasons for non-adher-
ence were forgetfulness (60%), being away from home 
(45.4%), running out of pills (44.4%), inconvenient time 
schedule (40.9%), polypharmacy (39.5%), lack of the 
prescribed brand in the pharmacy (35.9%), feeling well 
(35.9%), and fear of side effects (29.6%).The pharma-
cist-patient relationships were seen differently on each 
side (p<0.05 in 5 of 8 questions). Only 14.3% of inter-
viewed pharmacists asked patients to repeat the advice 
out loud, i.e. how to take the prescribed medicine. 
Conclusion
Patients’ adherence to long-term medication is low 
in Zagreb. The strategy for interventions to change 
patients’ behaviour towards prescribed medication 
should be widely established. The role of pharmacists 
could be explored more.
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describe the patient’s relationship towards medication. 
The term “compliance” has been used very often in de-
scribing the patient following a doctor’s advice4. Modern 
researchers emphasize that the notion of adherence also 
includes the patient’s compulsion with future medical 
treatments, not just mere use of doctors’ advice. We of-
ten use the term “persistence”, which describes the char-
acter of the patient in relation to the agreement reached 
with the doctor on medication5.
How to determine patient adherence?
by reviewing literature, five different basic methods of 
patient adherence determination could be identified:
 ▶ as the doctor’s opinion based on the examina-
tion and discussion with the patient, i.e. an eval-
uation of therapeutic outcomes;
 ▶ counting of the remaining pills when the patient 
delivers a drug package for checking and, of 
course, if the drug form is suitable for that meth-
od (for example, it is more difficult for medicines 
in the form of syrups or ointments);
 ▶ controlling of drug concentration or metabolites 
in the tissue, most commonly plasma;
 ▶ interviewing patients with standardized ques-
tionnaires,
 ▶ using electronic drug packaging devices that re-
cord exactly each bottle opening (assuming the 
pills are consumed!); an electronic medication 
event monitoring (eMEM), which is mainly used 
today in clinical therapeutic trials.
Each of these methods has its shortcomings, which the 
researcher must be aware of, and the results of each re-
search must be cautiously interpreted6.
MEtHODS
Patients’ adherence behaviour to the prescribed medi-
cation was studied by a cross-sectional method using 
an anonymized questionnaire. The 635 chronic patients 
participated (of 2000 asked) in a randomly selected sam-
ple of a total of 171 public pharmacies in the city of Za-
greb. The questionnaire was previously standardized5,7 
and approved by the Ethics Committee of the Faculty of 
Pharmacy and biochemistry in Zagreb. A piggyback sur-
vey on pharmacist-patient relationship was carried on in 
84 pharmacies, which voluntarily agreed to participate.
INtRODUCtION
Pharmacotherapy is a part of basic medical discipline. It 
has particularly developed in the second half of the 20th 
century following a discovery of new drugs. It is important 
to prescribe the right dosage in the right dosing intervals to 
a certain patient. The understanding of pharmacodynam-
ics and pharmacokinetics of a prescribed medicine is a cru-
cial doctor’s skill. If the prescribed medicine is ineffective 
after a certain period of treatment, it should be considered 
as wrongly selected. The doctor will then change the medi-
cation and try with a new therapeutic regimen.
Is it likely that the patient has not taken the medicine at 
all, or has taken a wrong dose or failed to comply with 
the dosing intervals? According to some research, 4% 
of patients do not take their medicine at all, and 50% 
of patients, especially the ones suffering from chronic 
diseases, take prescribed medicine improperly: skip the 
dose very often, forget to take the medicine, or change 
the therapeutic schemes, for example, they introduce 
the so-called weekend break1. Studies show that such 
behaviour towards the prescribed therapy is deteriorat-
ing further over time2. It has been shown that 20% of 
patients do not adhere to prescribed therapies after 60 
days and 50% after 300 days, despite their beliefs that 
they are taking an effective drug that, for example, con-
trols their blood cholesterol level3. Thus, the success of 
pharmacotherapy depends not only on the choice of 
the right medicine, the prescribing of the right dosage 
and choosing the right drug administration scheme, 
but also on patient adherence to the prescribed thera-
py, which is an important factor.
adherence definition
Adherence is a term that was first used at the beginning 
of the 21st century and is defined as the level in which the 
patient’s behaviour towards the prescribed medication 
corresponds with the doctor’s prescribed dosage sched-
ule1. Thus, it involves a relationship between the doctor 
and the patient, during which they discussed potential 
therapies as partners, agreed and jointly adopted a 
medical plan for the next treatment period. Although the 
problem of non-adherence to the doctor’s instructions 
was noticed as early as in the seventies of the last centu-
ry, the approach to dealing with it has gone through vari-
ous stages of evaluation and intervention. According to 
the available literature, there are various synonyms that 
Čulig J. Patients’ Adherence to Prescribed Medication. J. appl. health sci. 2018; 4(1): 7-14  9
by 45.4% and 44.4% patients, respectively. Patients 
and pharmacists were asked 8 questions that describe 
their relationship when taking medication (Table 3). 
There are statistically significant differences in patient 
and pharmacist attitudes in five areas (bold in Table 3, 
p <0.05). When asked “Has the pharmacist asked you 
about your attitude towards your drug therapy?”, 58.3% 
of the patients and 36.9% of the pharmacists respond-
ed positively (“Yes.”). Only 46.8% of the patients and 
75% of the pharmacists agreed with the statement “The 
pharmacist informed me why it is important to adhere 
to the prescribed therapy”. “The pharmacist advised in 
detail how to take the drug” was confirmed by 57.2% of 
RESUltS
Data in Table 1 shows the relationship between adher-
ence and demographic data of patients participating in 
the study. Most of the patients were older than 66 (249). 
Total adherence rate was 41.7%. Patients were offered 
the possibility of 16 reasons why they did not take the 
medication as prescribed (Table 2). “I just forgot” was 
the reason mentioned by 381 patients (60.0%). “I was 
not at home” and “I didn’t re-fill my supply” were used 
Table 1. Adherent /Non-adherent according to age and gender
AGE GROUP
Adherent Non-adherent
n % n %
26 – 35 16 32.0 34 68.0
36 – 45 22 42.3 30 57.7
46 – 55 50 41.0 72 59.0
56 – 65 62 38.3 100 61.7
66+ 115 56.2 134 53,8
total 265 41.7 370 58.3
GENDER n % n %
Male 109 42.4 148 57.6
Female 156 41.3 222 58.7
total 265 41.7 370 58.3
Table 2. Reasons for non-adherence to their medication in the study population
N percentage
I just forgot. 381 60.0
I was not at home. 288 45.4
I didn’t re-fill my supply. 282 44.4
I didn’t take my medication on time. 260 40.9
I take a number of drugs several times a day. 251 39.5
The prescribed drug was not available. 228 35.9
I felt well, I didn’t need medication. 228 35.9
I was afraid of side effects. 188 29.6
My doctor changes my therapy. 165 26.0
I was afraid that drug can be toxic. 150 23.6
I fell asleep before the time for my dose. 145 22.8
I was depressed. 145 22.8
I was afraid of developing dependence. 143 22.5
I had a cold / flu. 133 20.9
The prescribed drug was too expensive. 132 20.8
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in interruption of therapy with a beta blocker, which 
may result in angina due to increased sympathetic 
activity. It is therefore important that the patient be 
persistent and does not change the self-initiated dos-
age regimen. It is very common that patients forget 
one daily dose, most often at noon or in the evening, 
which we observed in our research. Otherwise, the oc-
currence of the change in the dosing interval is known; 
this can cause a condition in which the patient is un-
derdosed. Less frequent dosing pattern is common in 
non-adherent patients. It should be noted that skipping 
one or two doses may in some circumstances mean 
an absolute therapeutic failure (for example, insulin in 
diabetes type I). It is, in fact, surprising that considering 
such a low adherence in chronic patients (an average of 
about 40%), therapeutic failures are not more frequent. 
It seems that part of the explanation lies in the fact that 
dosing of some drugs is too high. Namely, a survey of 
documentation of newly registered drugs in the United 
States in the period from 1980 to 2000 has shown that 
in 22% of cases the recommended doses based on real-
world evidence were reduced up to 50% of initial rec-
ommendations in the registration files10. Thus, clinical 
trials that precede the registration of a drug are carried 
out with higher doses of medicine than is usually nec-
essary. This can be interpreted by the desire to achieve 
a statistically significant advantage of the new therapy 
before the registration. This results in a better negoti-
ating position of the pharmaceutical industry when de-
termining the price of a drug on the market. However, 
multiple doses are associated with a higher risk of side 
effects, so doctors need to keep an eye on it when they 
patients and 90.5% of pharmacists. The question “Do 
you skip the prescribed dose of your medicine” was set 
up by only 28.6% of pharmacists!
DISCUSSION 
The therapeutic success of prescribed medication de-
pends on the patient’s adherence. For example, despite 
the existence of highly effective antihypertensive drugs, 
some studies show that only 30% of patients in the Unit-
ed States achieve adequate blood pressure control1. In 
Zagreb, according to our research, it is somewhere be-
low 40%8. Well-known high-risk complications of un-
regulated blood pressure are: 3-4 times greater chance 
of ischemic heart disease, and 3 times greater incidence 
of stroke4. In addition to the positive therapeutic effect, 
different side effects are associated with drug use. How-
ever, in our research it has been shown that persistent 
patients have statistically significantly fewer overall 
health problems than the unreliable ones8. It is impor-
tant to warn the patient about any possible side effects, 
such as, for example, orthostatic hypotension in some 
antihypertensive agents, so as not to be disappointed 
with the effect of the drug and give up the prescribed 
medication. Sometimes patients apply the so-called 
“weekend breaks” technique, which in some cases may 
cause adverse effects, such as a feedback phenomenon 
Table 3. Patients’ and pharmacists’ answers regarding pharmacists’ advice on drug treatment
Questions
1 2
n % n %
Has the pharmacist asked you whether you are taking the drug for the first time? 391 61.6 61 72,6
Has the pharmacist asked you to repeat aloud the instructions on how to take the drug? 145 22.8 12 14,3
Has the pharmacist informed you on the importance of complying with the prescribed therapy? 297 46.8 63 75.0
Has the pharmacist advised you in detail on how to take the drug? 363 57.2 76 90,5
Has the pharmacist advised you on combining your therapy with OTC drugs? 344 54,2 57 67.9
Has the pharmacist advised you on solving the possible drug side effects? 277 43,6 41 48.8
Has the pharmacist asked you about skipping your therapy doses and why? 265 41.7 24 28.6
Has the pharmacist asked you about your attitude towards your drug therapy? 370 58.3 31 36.9
TOTAL 635 100.0 84 100.0
1) The patient stated that the pharmacist always asks him/her the question.
2) The pharmacist stated that he/she always asks the patient the question.
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our research has shown that patients are not entirely 
satisfied with the existing situation; they complain of 
too many drug changes, lack of medicines or too little 
time for discussion with the doctor about the type of 
medication and the possible consequences of taking 
the drug. Doctors complain that too much paperwork 
leaves them with insufficient time for each patient. Ac-
cording to our research, a potential resource that could 
affect the patient’s adherence are pharmacists in public 
pharmacies. We found that patients received less in-
formation from the pharmacist than they expected11. 
The average drug delivery lasts about 5.26 minutes in 
pharmacies in Zagreb if the patient comes for the first 
time to get the prescribed drug, and only 2.21 minutes 
if they have to refill the drug. In Zagreb we started an in-
tervention project in which pharmacists were trained to 
inform the patient about the importance of adherence 
to the prescribed medication. Similar programs already 
exist in the UK and Switzerland12. It is assumed that the 
severity of the disease affects adherence. In our study, 
we did not find a significant difference between chronic 
diseases that were analysed (hypertension, hyperlipi-
daemia, diabetes, asthma, chronic back pain). A com-
plicated dosage schedule, multiple drug interactions, 
the influence of various supplements that the patient 
is taking together with the prescribed therapy, includ-
ing the consumption of alcohol and the free-for-sale 
preparations (OTC and complementary medicine), sig-
nificantly affect adherence. It has been shown that one-
off daily treatment has better adherence, since patients 
often forget one dose if they take their medication, for 
example, in the morning and evening (more often in the 
evening!). Of course, the one-off dose tendency also 
has higher risks of therapeutic failure if the patient is 
unsettled, as we have already mentioned in Table 4. 
Therefore, it is good to plan the therapy scheme with 
the patient and help them fit it into their daily routines 
and duties so that they would not fail to take the dose 
“because they were not at home”, which was the case 
with 67.5% of our unsightly patients (Table 2). However, 
it seems that the most important factor for adherence is 
the patient’s personal motivation. The patient’s knowl-
edge about the disease, the motivation to be cured, 
the belief in the agreed treatment process, and the ex-
pected therapeutic success certainly have a significant 
impact on the implementation of the agreement with 
the doctor. Still, it is not all that easy, especially in long-
term treatment with relatively small improvements in 
the patient’s condition, aimed at preventing potential 
deterioration, which the patient does not quite under-
stand and then dislikes as a motive. 
start prescribing newly registered medicines. Fear of 
side effects of a drug is one of the factors that affects the 
patient’s adherence behaviour. In our study, as many as 
29.6% of non-adherent patients cited fear of side effects 
as a cause5. An interesting study of adherence to medi-
cation with doxycycline for the treatment of chlamydial 
infection has emerged in the literature. Doxycycline is 
prescribed 2 x 100 mg daily for 7 days as a standard 
dose. It was found that the therapeutic success was 
the same in patients who took 100% of the prescribed 
dose and those who took only 25% of the prescribed 
dose of doxycycline3! The second question is whether 
such patient behaviour in terms of therapy can cause 
other side effects, such as the development of resistant 
strains of bacteria during antimicrobial treatment. It is 
therefore important to know the factors that influence 
the patient’s adherence to medication. Adherence to 
medication is a multifactorial problem. We can divide 
reasons that affect adherence into 5 different groups: 
socioeconomic factors (level of wealth), organization of 
the health service (primary care doctors, pharmacists 
in public pharmacies and other health professionals in-
volved in the provision of medical services), the charac-
teristics of the disease for which the patient takes medi-
cation (for example , the severity of symptoms, such as 
pain), the characteristic of the medication itself (for ex-
ample, multiple medication dosage at once, complicat-
ed therapeutic scheme, frequent changes in prescribed 
drugs), and finally a group of factors that represent the 
patient’s personality (education, age, beliefs, percep-
tion of the disease)11. 
Although studies do not show consistent conclusions, a 
lower socioeconomic status of the patient, unemploy-
ment, unhygienic living conditions, and cultural preju-
dices must be considered as factors which affect adher-
ence. In Europe, the share of the elderly population in 
the total population is growing. This increases the num-
ber of chronic diseases, as well as the consumption of 
drugs. The risk of poor adherence among the elderly 
patients lies in the fact that elderly people usually have 
more than one chronic illness, which usually means 
that more than one drug is prescribed at the same time. 
They often suffer from cognitive impairment, which 
increases the chance of misusing the dosing scheme. 
In our group of patients, we found that adherence in-
creased with age8! This may, however, lead to increased 
incidence of side effects and drug interactions. The 
health care organization can play a crucial role in gain-
ing patient’s trust and consequently improving their ad-
herence to the prescribed medication. Unfortunately, 
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riod of 3-4 half-lives of the drug. The survey found that 
the patient’s adherence assessment, if standardized, is 
susceptible to the subjectivity of the patient and his/
her desire to substantiate the answers he/she pre-
sumes will appeal to the doctor. However, if the poll is 
anonymous, that is, if the patient is convinced that he/
she cannot be identified on the basis of the response, 
the data presented can be very useful at the popula-
tion level. Such findings can be of key importance in 
the planning of intervention programs to improve pa-
tient adherence to premature medical practice14. 
based on the survey of literature from 1970 to the pre-
sent day, a list of documented cases may be drawn up 
in which the missed drug dose or drug intake according 
to the agreed treatment scheme resulted in significant 
clinical outcomes15.
Table 4. list of drugs for whose efficacy 
patient adherence is important 
1. Non-intrinsic sympathomimetic activity (atenolol, betaxolol)
2. ACE inhibitors (enalapril, trandolapril) 
3. Oral contraception - combined steroid hormones
4. Calcium channel blockers (amlodipine, diltiazem, nifedipine)
5. Antidepressants (paroxetine, sertraline, fluoxetine)
6. Antimicrobial therapy (combined antiretroviral therapy) 
7. Combined antihypertensive therapy 
8. glycaemic control therapy (insulin) 
9. Hypolipemics 
10. Anticoagulant therapy (warfarin) 
11. Antiepileptics (phenytoin, carbamazepine) 
12. Antiasthmatics (inhaled corticosteroid) 
13. Immunosuppressants (cyclosporine in transplant patients)
Apparently, in real-life practice, there are other exam-
ples in which therapeutic failure has led to patient’s 
inadvertence but they have not been adequately ex-
plored. Haynes, one of the pioneers in the field of ad-
herence, once stated: “Increased patient’s adherence to 
medication can have far greater significance for better 
population health than new (innovative) medical ther-
apy4.” Of course, we do not have to (and will not) agree 
completely with this statement, but we certainly must 
not neglect it! 
Adherence will be affected by a variety of factors such 
as forgetfulness, psychosocial stress, anxiety due to 
potential side effects, disliking attitude towards chem-
ical preparations, fear of addiction, depressive mood, 
and absence of devotion to the agreement reached 
with the doctor. In addition, various public affairs con-
cerning the doctors, the pharmaceutical industry and 
some ethical aspects have recently been mentioned, 
all of which affect the sensitive issue of adherence to 
medicine. We have already noted that the patient ad-
herence measuring methods have limited sensitivity 
and precision. It is surprising that the doctoral evalu-
ation is least reliable in assessing adherence! Patients 
will rarely admit to their doctor that they did not take 
the prescribed medication as they previously agreed. 
They are afraid of cheating, embarrassed to disappoint 
the doctor, and they do not want the doctor to blame 
them. Unfortunately, this will lead to a completely 
wrong doctor’s position in the event of absence of a 
positive treatment outcome. He/she will conclude that 
the drug is not effective, so the doctor will change or 
increase the dose or add another cure. A good is exam-
ple is the published case of the refractory hypertension 
research. Namely, a group of researchers at the Swiss 
Hypertension Clinic continued the same treatment 
with which the patients diagnosed with refractory hy-
pertension were admitted to the department (3). The 
eMEM adherence measurement method was applied. 
It was found that even in 50% of cases, the diagnosis 
of refractory hypertension was wrong! Patients did not 
take the prescribed therapy. After an agreement with 
the doctor and an explanation of the importance of 
adhering to the agreement on prescribed medication, 
the blood pressure was normalized with initial treat-
ment. The doctor can rely on the counting of the pills 
if they ask the patient to take the medicine on each 
check. It has been shown, however, that adherence 
can be evaluated by this method. In 1989, Pullar et al. 
published a comparative study of tablet counting and 
plasma concentration measurements. They concluded 
that pill counting method should be forgotten13. In ad-
dition, the so-called “white coat” influence is known. A 
few days before the check-up and visit to the doctor’s 
office, patients begin taking their prescribed therapy 
regularly. Measurement of drug or metabolite concen-
tration in blood, urine or saliva is an objective method. 
The limitation of the interpretation of findings of adher-
ence assessment is in the pharmacokinetic properties 
of the drug. Modern pharmacotherapy generally uses 
drugs that are T ½ about 12 hours. Thus, the measured 
drug concentration in the body is an indicator of a pe-
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CONClUSION
The adherence of patients to prescribed medication is 
a widespread problem. It is estimated that adherence 
in the treatment of chronic diseases is only about 50%. 
Since the share of chronic diseases in the population 
is increasing, it is estimated that in 2020 the number 
will increase to 65% (mental illness, consequences of 
atherosclerotic changes, human immunodeficiency 
virus). This problem should not be ignored in terms 
of population health status, but also economic dam-
age, both direct and indirect, resulting from the cost of 
prescribed medication. better adherence will improve 
the patients’ quality of life, but also prevent unwanted 
events that may occur due to non-adherence with the 
agreed therapeutic scheme. It is a fact that patients 
have problems with sticking to the agreed therapeutic 
scheme either for personal reasons of forgetfulness or 
convenience, the complicated treatment scheme, or 
insufficient explanation that the prescribed medication 
has to be taken regularly. The health care organization 
needs to be restructured to better serve the patients. 
It also must adapt to the adequate resources and time 
available for the development of partner relationships 
between the doctor and the patient. We are witness-
ing health reforms aimed at improving administration, 
rationalizing financial resources, and dealing with the 
adaptation of the relationship between healthcare pro-
fessionals and healthcare providers. As patient adher-
ence is multifactorial, intervention needs to be subtle 
and diverse. It should not be basically criticism, but en-
couragement and motivation. Therefore, health profes-
sionals need to be educated in communication skills, 
which are not sufficiently taught during their educa-
tion at the medical and pharmaceutical faculties. It is 
also necessary to create a new role of the pharmacist, 
which by only dispensing the prescribed medicines has 
threatened the foundation of its profession. The phar-
macotherapeutic model in the public pharmacy that 
promotes patient adherence to the prescribed medica-
tion is a useful challenge. 
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Rezultati
Prosječna adherencija prema dugotrajnoj medikaciji bi-
la je 41,7 %, dok je u kohorti pacijenata s hipertenzijom 
bila čak i niža (39 %). Kao glavni razlog neadherencije 
pacijenti su navodili zaboravljivost (60  %), zatim nisu 
bili kod kuće u vrijeme uzimanja lijeka (45,4 %), ili im je 
uzmanjkalo lijeka (44,4 %) ili je propisano vrijeme uzi-
manja lijeka bilo nezgodno (40,9 %) odnosno uzimaju 
više različitih lijekova (39,5 %). Također se navodi razlog 
da nije bilo propisanog lijeka u ljekarni, a nisu mogli do-
biti zamjenu (35,9 %), neki su se osjećali dobro (35,9 %) 
ili su htjeli izbjeći neželjene učinke lijeka (29,6 %). Od-
nos pacijent – ljekarnik sudionici u studiji različito su 
ocijenili (u čak pet od osam pitanja odgovori su se ra-
zlikovali statistički značajno, p < 0,05). Na primjer, samo 
14,3 % ispitanih ljekarnika traži od pacijenta da glasno 
ponovi uputu o uzimanju propisane medikacije.
Zaključak
U Zagrebu je razina adherencije pacijenata prema du-
goročnoj terapiji niska. Potrebno je strateški planirati i 
intervenirati kako bi se ponašanje pacijenata promije-
nilo. Moguće je kreirati novu ulogu farmaceuta u proce-
su povećanja adherencije prema propisanoj medikaciji.
Ključne riječi: adherencija, pridržavanje uputa liječnika, ustraj-




Adherencija se definira kao razina pacijentova pridrža-
vanja dogovora s liječnikom o propisanoj medikaciji. 
Procjenjuje se da je prosječna neadherentnost pacijenta 
prema dugotrajnoj terapiji kod kroničnih bolesti u razvi-
jenim zemljama oko 50  %. Slaba adherencija glavni je 
razlog neuspješnoga kliničkog ishoda, ali i potencijal-
nog trošenja sredstava za liječenje komplikacija bolesti 
uslijed neuspješnog liječenja. Proveli smo istraživanje u 
Zagrebu kod bolesnika kojima je propisana dugotrajna 
medikacija zbog kroničnih bolesti
Metode
Pacijenti su intervjuirani prigodom posjeta javnoj lje-
karni koja je sudjelovala u ispitivanju i uzimanja lijeka 
za kroničnu terapiju na recept. Standardizirani intervju 
odobrilo je Etičko povjerenstvo i pacijentu se jamčila 
anonimnost. Ukupno je prikupljeno 635 anketa. Studi-
ja je planirana kao presječna. Dio pitanja odnosio se na 
odnos ljekarnika i pacijenta. Samo 84 ljekarnika prista-
lo je sudjelovati u istraživanju.
ADHERENCIJA PACIJENAtA PREMA PROPISANOJ MEDIKACIJI
